Xylem Inc. (XYL) Sets New 1-Year High at $48.81
Shares of Xylem Inc. (NYSE:XYL) hit a new 52-week high during trading on Thursday . The company traded as high as $48.81 and last traded at $48.68, with a volume of 442,776 shares. The stock had previously closed at $47.89.
Several equities analysts have recently issued reports on the company. Barclays PLC upped their target price on Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a report on Monday, July 18th. Zacks Investment Research lowered Xylem from a “buy” rating to a “hold” rating in a report on Friday, July 15th. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and issued a $52.00 target price (up from $46.00) on shares of Xylem in a report on Monday, June 20th. Royal Bank Of Canada raised Xylem from a “sector perform” rating to an “outperform” rating and upped their target price for the company from $37.00 to $42.00 in a report on Wednesday, June 1st. Finally, Canaccord Genuity reaffirmed a “hold” rating and issued a $42.00 target price on shares of Xylem in a report on Wednesday, May 4th. Nine research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Xylem presently has an average rating of “Hold” and an average target price of $42.25.
The company has a market cap of $8.68 billion and a PE ratio of 25.87. The stock has a 50 day moving average of $46.48 and a 200-day moving average of $42.28.
Xylem (NYSE:XYL) last released its earnings results on Tuesday, August 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.47 by $0.01. The business had revenue of $932 million for the quarter, compared to analysts’ expectations of $927.69 million. During the same quarter in the previous year, the business posted $0.43 earnings per share. Xylem’s revenue for the quarter was up 1.3% on a year-over-year basis. Analysts forecast that Xylem Inc. will post $2.04 EPS for the current year.
In related news, Director Steven R. Loranger sold 50,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 1st. The shares were sold at an average price of $44.52, for a total value of $2,226,000.00. Following the completion of the transaction, the director now directly owns 12,588 shares in the company, valued at approximately $560,417.76. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Steven R. Loranger sold 33,887 shares of the business’s stock in a transaction that occurred on Thursday, August 11th. The stock was sold at an average price of $48.11, for a total transaction of $1,630,303.57. Following the completion of the transaction, the director now owns 11,243 shares of the company’s stock, valued at $540,900.73. The disclosure for this sale can be found here.
A number of large investors recently bought and sold shares of the company. Comerica Bank increased its stake in Xylem by 1.8% in the fourth quarter. Comerica Bank now owns 43,551 shares of the company’s stock worth $1,497,000 after buying an additional 774 shares during the period. Morgan Stanley increased its stake in Xylem by 2.3% in the fourth quarter. Morgan Stanley now owns 340,028 shares of the company’s stock worth $12,411,000 after buying an additional 7,676 shares during the period. Aberdeen Asset Management PLC UK increased its stake in Xylem by 24.9% in the fourth quarter. Aberdeen Asset Management PLC UK now owns 35,358 shares of the company’s stock worth $1,259,000 after buying an additional 7,040 shares during the period. KBC Group NV increased its stake in Xylem by 27.0% in the fourth quarter. KBC Group NV now owns 185,037 shares of the company’s stock worth $6,754,000 after buying an additional 39,313 shares during the period. Finally, Utah Retirement Systems increased its stake in Xylem by 0.3% in the fourth quarter. Utah Retirement Systems now owns 32,465 shares of the company’s stock worth $1,185,000 after buying an additional 100 shares during the period.
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.